Dr. Reddy's Laboratories Ltd. (RDY)
13.21
-0.02
(-0.15%)
USD |
NYSE |
Oct 23, 16:00
13.10
-0.11
(-0.83%)
After-Hours: 20:00
Dr. Reddy's Laboratories Price to Book Value : 2.731 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.731 |
| October 22, 2026 | 2.735 |
| October 21, 2026 | 2.727 |
| October 20, 2026 | 2.741 |
| October 19, 2026 | 2.704 |
| October 16, 2026 | 2.702 |
| October 15, 2026 | 2.667 |
| October 14, 2026 | 2.636 |
| October 13, 2026 | 2.640 |
| October 12, 2026 | 2.650 |
| October 09, 2026 | 2.580 |
| October 08, 2026 | 2.522 |
| October 07, 2026 | 2.536 |
| October 06, 2026 | 2.582 |
| October 05, 2026 | 2.547 |
| October 02, 2026 | 2.532 |
| October 01, 2026 | 2.532 |
| September 30, 2026 | 2.609 |
| September 29, 2026 | 2.642 |
| September 28, 2026 | 2.573 |
| September 25, 2026 | 2.519 |
| September 24, 2026 | 2.529 |
| September 23, 2026 | 2.548 |
| September 22, 2026 | 2.585 |
| September 21, 2026 | 2.55 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.507 |
| September 17, 2026 | 2.507 |
| September 16, 2026 | 2.402 |
| September 15, 2026 | 2.375 |
| September 14, 2026 | 2.449 |
| September 11, 2026 | 2.447 |
| September 10, 2026 | 2.408 |
| September 09, 2026 | 2.443 |
| September 08, 2026 | 2.443 |
| September 04, 2026 | 2.462 |
| September 03, 2026 | 2.474 |
| September 02, 2026 | 2.503 |
| September 01, 2026 | 2.503 |
| August 31, 2026 | 2.494 |
| August 28, 2026 | 2.505 |
| August 27, 2026 | 2.501 |
| August 26, 2026 | 2.513 |
| August 25, 2026 | 2.538 |
| August 24, 2026 | 2.513 |
| August 21, 2026 | 2.505 |
| August 20, 2026 | 2.490 |
| August 19, 2026 | 2.490 |
| August 18, 2026 | 2.499 |
| August 17, 2026 | 2.490 |
| August 14, 2026 | 2.523 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 1.376 |
| Teva Pharmaceutical Industries Ltd. | 5.922 |
| AstraZeneca PLC | 11.24 |
| ANI Pharmaceuticals, Inc. | 2.793 |
| Corcept Therapeutics, Inc. | 13.13 |
Price to Book Value Related Metrics
| PE Ratio | 36.30 |
| PS Ratio | 3.092 |
| Price to Free Cash Flow | 357.00 |
| Price | 13.21 |
| Earnings Yield | 2.75% |
| Market Cap | 11.00B |
| Operating PE Ratio | 34.56 |
| Normalized PE Ratio | 35.64 |